This HCP participates in the ERNDIM Quality Assessment scheme (2019)
No information was provided.
Hôpital Antoine Béclère, Service de Pédiatrie – AP-HP
|
Division of Inherited Metabolic Diseases Reference Centre Expanded Newborn Screening |
Contact Person Alberto Burlina
In-house metabolic lab (IH)
|
segremet@aopd.veneto.it |
Metabolite Tests | |
Type of Test | Name of |
Amino and organic acids disorders (AOA) | |
Urine | Amino acids quantitative |
Amino acids qualitative | |
Carnitine Total, Free | |
Glycerate | |
Homocitrulline (special assay) | |
Organic acids qualitative | |
Organic acids quantitative | |
Orotic acid | |
Oxalate | |
Succinylacetone | |
Sulfite test | |
Plasma
|
Acylcarnitines |
Carnitine, free and total | |
Methylmalonic acid (MMA) | |
Organic Acids profile | |
Total homocysteine | |
Succinylacetone | |
Dry Blood Spots | Aminoacids |
Acylcarnitines | |
Total homocysteine | |
Methylmalonic acid | |
CSF | Aminoacids |
Fatty Acid Oxidation (C-FAO Disorders) | |
Plasma | 3-OH-butyrate and acetoacetate |
Dry Blood Spots | Gal and Gal-1P semiquantitative |
Lysosomal Storage Disorders (LSD) | |
Urine | Glycosaminoglycans quantitative |
Oligosaccharides TLC | |
Oligosaccharides/glycosaminoglycans by mass spectrometry | |
Plasma | Glycosylsphingosine |
Lyso-Gb3 | |
Glucosylceramide | |
Hexosylsphingosine (LysoGL1) | |
Peroxisomal Disorders (PD) | |
Plasma | 7-Dehydrocholesterol |
7-Ketocholesterol | |
Cholestane-3?,5?,6?-triol | |
Phytanic acid | |
Pristanic acid | |
Very long chain fatty acids- VLCFA | |
Congenital Disorders of glycosylation and Disorders of intracellular trafficking (CDG) | |
Plasma | N-Glycosylation: Capillary electrophoresis |
Disorders of Neuromodulators and other small Molecules (NOMS) | |
Urine | Alpha-aminoadipic semialdehyde |
L-Pipecolic acid | |
Pterines | |
Purines and pyrimidines | |
Plasma | Alpha-aminoadipic semialdehyde |
CSF | 3-methoxytyrosine |
Alpha-aminoadipic semialdehyde | |
5-methyltetrahydrofolate | |
N-acetylaspartylglutamic acid (NAAG) | |
Neurotransmitters | |
Pipecolic acid | |
Pterins | |
Disorders of Pyruvate Metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD) | |
Urine | Creatine |
Creatinine | |
Guanidinoacetate | |
Plasma | Creatine |
Guanidinoacetate |
Enzyme Tests | ||
Type of Disease | Yes or No | |
Amino and organic acids disorders (AOA) | ||
Aminoacidopathies | No | |
Organic Acidurias | No | |
Urea cycle disorders | No | |
Fatty Acid Oxidation (C-FAO Disorders) | ||
Glycogen storage diseases |
No
|
|
Carbohydrate diseases other than Glycogen storage diseases |
No | |
Fatty acid oxidation and carnitine transport disorders |
Yes | |
Disorders of Ketogenesis and Ketolysis | No | |
Lysosomal Storage Disorders (LSD) | ||
Mucopolysaccharidoses
|
Yes | |
Sphingolipidoses | Yes | |
Oligosaccharidosis | Yes | |
Mucolipidoses | Yes | |
Lysosomal glycogen storage disease (Pompe disease) | Yes | |
Peroxisomal Disorders (PD) | ||
Peroxisome biogenesis | Yes | |
Single peroxisomal enzyme deficiencies | Yes | |
Disorders of Cholesterol synthesis | Yes | |
Bile Acid Synthesis | No | |
Phospholipid and Glycosphingolipid Synthesis | Yes | |
Congenital Disorders of glycosylation and Disorders of intracellular trafficking (CDG) | ||
N-glycosylation disorders | No | |
O-glycosylation disorders | No | |
Disorders of Neuromodulators and other small Molecules (NOMS) | ||
Neurotransmitter disorders | No | |
Porphyrias | No
|
|
Disorders of Purine and pyrimidine metabolism | No | |
Disorders of Pyruvate Metabolism, Krebs cycle defects, mitochondrial oxidative phosphorylation disorders, disorders of thiamine transport and metabolism (PM-MD) | ||
Creatine metabolism | No | |
Pyruvate dehydrogenase | No | |
TCA-cycle enzymes | No | |
Respiratory chain disorders | No |